Hartman N R, Jardine I
Department of Pharmacology, Mayo Clinic, Rochester, MN 55905.
Drug Metab Dispos. 1987 Sep-Oct;15(5):661-4.
Thirteen metabolites of cyclosporine were isolated from the bile of rabbits receiving intravenous cyclosporine. The molecular weights of these metabolites were determined by fast atom bombardment mass spectrometry. These molecular weights were consistent with hydroxylated, N-demethylated, and carboxylated metabolites of cyclosporine as described previously. The in vitro activities of the metabolites were established using mitogen-stimulated lymphocyte proliferation assays. Only the two monohydroxylated metabolites were found to have significant activity, this being between 5 and 10% of that of the parent drug. The metabolites were also compared with cyclosporine in two commercial radioimmunoassay kits. The metabolites were found to cross-react with the parent drug in amounts ranging from 20 to 100%, with the least polar metabolites cross-reacting the most strongly. It is concluded that the cross-reacting metabolites measured by the presently available radioimmunoassays for cyclosporine probably do not represent significant additional immunosuppressive activity in vivo.
从静脉注射环孢素的兔子胆汁中分离出了13种环孢素代谢物。这些代谢物的分子量通过快原子轰击质谱法测定。这些分子量与先前描述的环孢素的羟基化、N-去甲基化和羧基化代谢物一致。利用丝裂原刺激的淋巴细胞增殖试验确定了这些代谢物的体外活性。仅发现两种单羟基化代谢物具有显著活性,其活性为母体药物活性的5%至10%。还在两种商用放射免疫分析试剂盒中将这些代谢物与环孢素进行了比较。发现这些代谢物与母体药物的交叉反应量在20%至100%之间,极性最小的代谢物交叉反应最强。得出的结论是,目前可用的环孢素放射免疫分析所测定的交叉反应代谢物在体内可能不代表显著的额外免疫抑制活性。